Matano S, Ryoyama K, Nakamura S, Okada G, Nomura T
Department of 3rd Intern. Med., School Med., Kanazawa Univ., Ishikawa, Japan.
Cancer Lett. 1995 May 4;91(1):93-9. doi: 10.1016/0304-3835(94)03722-u.
In vitro cultured r/mHM-SFME-1 cells were injected into the hind foot pads of Balb/c mice. Metastasis was detected in the lungs of tumor-bearing mice by means of both PCR and histological methods. Primers for the PCR were set to amplify a 128 bp exon-1 sequence of the human c-Ha-ras1 gene which had been introduced into the cells. Resulted PCR bands were densitometorically quantified using a bioimage analyzer, and more than 1 x 10(4) tumor cells were detectable in the mouse lung. The number of tumor cells per lung estimated from the amount of PCR products was 1 x 10(5), 15 x 10(5), 1 x 10(5) and 40 x 10(5) on days 7, 14, 21 and 28 respectively after the tumor injection. No metastases were histologically observed on days 7 and 14. Then, the possibility of using this model system for evaluation of a treatment against micro-metastases is discussed.
将体外培养的r/mHM-SFME-1细胞注射到Balb/c小鼠的后足垫中。通过PCR和组织学方法在荷瘤小鼠的肺部检测到转移。PCR引物用于扩增导入细胞中的人c-Ha-ras1基因的128 bp外显子1序列。使用生物图像分析仪对所得PCR条带进行光密度定量,在小鼠肺中可检测到超过1×10⁴个肿瘤细胞。根据PCR产物量估计,在肿瘤注射后第7、14、21和28天,每只肺中的肿瘤细胞数分别为1×10⁵、15×10⁵、1×10⁵和40×10⁵。在第7天和第14天,组织学上未观察到转移。然后,讨论了使用该模型系统评估针对微转移治疗的可能性。